Found: 10
Select item for more details and to access through your institution.
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Health economic studies of colorectal cancer and the contribution of administrative data: A systematic review.
- Published in:
- European Journal of Cancer Care, 2021, v. 30, n. 5, p. 1, doi. 10.1111/ecc.13477
- By:
- Publication type:
- Article
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- clinical trial
Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
- Published in:
- Radiation Oncology, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13014-021-01888-1
- By:
- Publication type:
- Article
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
- Published in:
- Radiation Oncology, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13014-021-01888-1
- By:
- Publication type:
- Article
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
- Published in:
- 2021
- By:
- Publication type:
- journal article